Clinical trial
Effect of HSV-2 Suppressive Therapy on Sexual Behavior
NCT00495716 · University of Washington, Other · Terminated
Key facts
| NCT number | NCT00495716 |
|---|---|
| Title | Effect of HSV-2 Suppressive Therapy on Sexual Behavior |
| Official title | Effect of Suppressive Therapy on Behavioral Determinants of HSV-2 Transmission |
| Lead sponsor | University of Washington, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Genital Herpes |
| Intervention type | Drug |
| Interventions | acyclovir |
| Enrollment | 72 |
| Start date | Jan 1, 2008 |
| Primary completion | Jun 1, 2010 |
| Completion | Jun 1, 2010 |
| First posted | Jul 3, 2007 |
| Last update posted | Mar 7, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: